ICON Public Limited (NASDAQ:ICLR) Receives Consensus Recommendation of “Buy” from Analysts

Shares of ICON Public Limited (NASDAQ:ICLR) have been given an average recommendation of “Buy” by the eight brokerages that are presently covering the firm, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $321.64.

A number of research firms have weighed in on ICLR. TD Cowen upped their price target on ICON Public from $343.00 to $349.00 and gave the stock a “buy” rating in a report on Friday. Mizuho reiterated a “buy” rating and set a $346.00 target price on shares of ICON Public in a research note on Thursday, April 4th. Truist Financial increased their target price on ICON Public from $357.00 to $367.00 and gave the company a “buy” rating in a research note on Friday, February 23rd. Evercore ISI reduced their target price on ICON Public from $350.00 to $330.00 and set an “outperform” rating for the company in a research note on Friday. Finally, Robert W. Baird increased their target price on ICON Public from $362.00 to $363.00 and gave the company an “outperform” rating in a research note on Friday.

Institutional Investors Weigh In On ICON Public

Large investors have recently added to or reduced their stakes in the stock. Steph & Co. increased its holdings in shares of ICON Public by 4.6% during the third quarter. Steph & Co. now owns 1,670 shares of the medical research company’s stock valued at $411,000 after purchasing an additional 73 shares during the period. Whittier Trust Co. increased its holdings in shares of ICON Public by 58.6% during the third quarter. Whittier Trust Co. now owns 2,544 shares of the medical research company’s stock valued at $626,000 after purchasing an additional 940 shares during the period. Kornitzer Capital Management Inc. KS increased its holdings in shares of ICON Public by 17.5% during the third quarter. Kornitzer Capital Management Inc. KS now owns 49,660 shares of the medical research company’s stock valued at $12,229,000 after purchasing an additional 7,385 shares during the period. NBC Securities Inc. acquired a new position in shares of ICON Public during the third quarter valued at $174,000. Finally, Motco boosted its stake in ICON Public by 766.4% during the third quarter. Motco now owns 1,291 shares of the medical research company’s stock valued at $318,000 after buying an additional 1,142 shares in the last quarter. 95.61% of the stock is owned by institutional investors and hedge funds.

ICON Public Stock Performance

NASDAQ ICLR opened at $308.31 on Friday. The business’s 50-day simple moving average is $318.89 and its 200-day simple moving average is $282.81. The firm has a market capitalization of $25.43 billion, a P/E ratio of 37.51, a P/E/G ratio of 1.46 and a beta of 1.15. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.21 and a quick ratio of 1.21. ICON Public has a 1-year low of $181.92 and a 1-year high of $344.77.

ICON Public (NASDAQ:ICLR) last released its quarterly earnings results on Wednesday, February 21st. The medical research company reported $3.40 earnings per share for the quarter, topping analysts’ consensus estimates of $3.27 by $0.13. The firm had revenue of $2.07 billion during the quarter, compared to analysts’ expectations of $2.08 billion. ICON Public had a return on equity of 11.84% and a net margin of 8.30%. Equities analysts predict that ICON Public will post 14.4 EPS for the current year.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.